| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1439-0507.2010.01967.X |
| P698 | PubMed publication ID | 21672043 |
| P50 | author | Jeanette Wagener | Q40196622 |
| P2093 | author name string | Martin Schaller | |
| Daniela Mailänder-Sánchez | |||
| P2860 | cites work | Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis | Q21136398 |
| Potential uses of probiotics in clinical practice | Q24681377 | ||
| Rationale for the luminal provision of butyrate in intestinal diseases | Q28143911 | ||
| Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy | Q28176406 | ||
| Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG | Q28234977 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| Adhesion of bacteria to resected human colonic tissue: quantitative analysis of bacterial adhesion and viability. | Q30779329 | ||
| In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli | Q31004513 | ||
| Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells | Q33554139 | ||
| Vaginal candidosis: epidemiological and etiological factors | Q34105393 | ||
| Understanding the bacterial flora of the female genital tract | Q34142051 | ||
| An overview of fungal infections | Q34162712 | ||
| Toll-like receptors as key mediators in innate antifungal immunity | Q34554648 | ||
| Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function | Q34587671 | ||
| Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review | Q34590426 | ||
| Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors | Q34619615 | ||
| Probiotic microorganisms: how they affect intestinal pathophysiology | Q34836542 | ||
| Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine | Q35591664 | ||
| A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients | Q35595192 | ||
| The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida | Q35614375 | ||
| Toll-like receptors and innate antifungal responses | Q35618740 | ||
| Probiotics and the management of inflammatory bowel disease. | Q35854517 | ||
| Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens | Q35890738 | ||
| Bacterial vaginosis--a microbiological and immunological enigma | Q36050730 | ||
| Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics | Q36220414 | ||
| Effects of probiotics on the gastrointestinal tract | Q36251686 | ||
| Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection | Q36370514 | ||
| Towards understanding molecular modes of probiotic action | Q36410699 | ||
| Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. | Q36530199 | ||
| Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species | Q36747076 | ||
| The mechanism of action of probiotics | Q36956063 | ||
| Genes and molecules of lactobacilli supporting probiotic action | Q36995291 | ||
| The safety of probiotics | Q37053047 | ||
| Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens | Q37074642 | ||
| IFN-gamma in Candida albicans infections | Q37410227 | ||
| Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial | Q37509609 | ||
| Regulation of Candida albicans morphogenesis by fatty acid metabolites | Q37582849 | ||
| Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm | Q39478505 | ||
| Immune response of non-pathogenic gram(+) and gram(-) bacteria in inductive sites of the intestinal mucosa study of the pathway of signaling involved | Q39878650 | ||
| Antimicrobial and antiadhesive properties of a biosurfactant isolated from Lactobacillus paracasei ssp. paracasei A20. | Q39897443 | ||
| Generation of NO by probiotic bacteria in the gastrointestinal tract | Q40294015 | ||
| Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid | Q40703200 | ||
| Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. | Q41450612 | ||
| Aggregating phenotype in Lactobacillus crispatus determines intestinal colonization and TLR2 and TLR4 modulation in murine colonic mucosa. | Q42058474 | ||
| Molecular characterization of a plasmid-borne (pTC82) chloramphenicol resistance determinant (cat-TC) from Lactobacillus reuteri G4. | Q42645875 | ||
| The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity | Q43233894 | ||
| Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV. | Q43696435 | ||
| Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages | Q44075491 | ||
| In vitro conjugal transfer of tetracycline resistance from Lactobacillus isolates to other Gram-positive bacteria | Q44538012 | ||
| The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis | Q44933430 | ||
| Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. | Q45015591 | ||
| Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. | Q46136429 | ||
| Fungal species changes in the female genital tract | Q46472948 | ||
| Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice | Q47713770 | ||
| Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro | Q50054659 | ||
| Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. | Q50773084 | ||
| Antimicrobial activity, inhibition of urogenital pathogens, and synergistic interactions between lactobacillus strains. | Q51613102 | ||
| Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. | Q51743349 | ||
| Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. | Q54511436 | ||
| P433 | issue | 1 | |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 17-26 | |
| P577 | publication date | 2011-06-14 | |
| P1433 | published in | Mycoses | Q1956531 |
| P1476 | title | Potential role of probiotic bacteria in the treatment and prevention of localised candidosis | |
| P478 | volume | 55 |
| Q42375693 | Antifungal defense of probiotic Lactobacillus rhamnosus GG is mediated by blocking adhesion and nutrient depletion |
| Q39035805 | Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis). |
| Q41018464 | In vitro evaluation on HeLa cells of protective mechanisms of probiotic lactobacilli against Candida clinical isolates. |
| Q38743672 | Newer patents in antimycotic therapy |
| Q40441902 | Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study |
| Q98771335 | The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris |
| Q36743194 | Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013) |
Search more.